Skip to main content
Top
Published in: Heart Failure Reviews 2/2014

01-03-2014

Co-morbidities in heart failure

Authors: Vincent M. van Deursen, Kevin Damman, Peter van der Meer, Peter J. Wijkstra, Gert-Jan Luijckx, Andre van Beek, Dirk J. van Veldhuisen, Adriaan A. Voors

Published in: Heart Failure Reviews | Issue 2/2014

Login to get access

Abstract

Heart failure is a clinical syndrome characterized by poor quality of life and high morbidity and mortality. Co-morbidities frequently accompany heart failure and further decrease in both quality of life and clinical outcome. We describe that the prevalence of co-morbidities in patients with heart failure is much higher compared to age-matched controls. We will specifically address the most studied organ-related co-morbidities, that is, renal dysfunction, cerebral dysfunction, anaemia, liver dysfunction, chronic obstructive pulmonary disease, diabetes mellitus and sleep apnoea. The pathophysiologic processes underlying the interaction between heart failure and co-morbid conditions are complex and remain largely unresolved. Although common risk factors are likely to contribute, it is reasonable to believe that factors associated with heart failure might cause other co-morbid conditions. Inflammation, neurohumoral pathway activation and hemodynamic changes are potential factors. We try to provide explanations for the observed association between co-morbidities and heart failure, as well as its impact on survival.
Literature
1.
go back to reference Authors/Task Force Members, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Document Reviewers, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14:803–869PubMedCrossRef Authors/Task Force Members, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Document Reviewers, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14:803–869PubMedCrossRef
2.
go back to reference Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42:1226–1233PubMedCrossRef Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42:1226–1233PubMedCrossRef
3.
go back to reference Zelis R, Sinoway LI, Musch TI, Davis D, Just H (1988) Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants. Am J Cardiol 62:2E–8EPubMedCrossRef Zelis R, Sinoway LI, Musch TI, Davis D, Just H (1988) Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants. Am J Cardiol 62:2E–8EPubMedCrossRef
4.
go back to reference Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582–588PubMedCrossRef Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582–588PubMedCrossRef
5.
go back to reference Kleijn L, Belonje AM, Voors AA, De Boer RA, Jaarsma T, Ghosh S, Kim J, Hillege HL, Van Gilst WH, Van Veldhuisen DJ, Van der Meer P (2012) Inflammation and anaemia in a broad spectrum of patients with heart failure. Heart 98:1237–1241PubMedCrossRef Kleijn L, Belonje AM, Voors AA, De Boer RA, Jaarsma T, Ghosh S, Kim J, Hillege HL, Van Gilst WH, Van Veldhuisen DJ, Van der Meer P (2012) Inflammation and anaemia in a broad spectrum of patients with heart failure. Heart 98:1237–1241PubMedCrossRef
6.
go back to reference van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16:84–90PubMedCrossRef van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16:84–90PubMedCrossRef
7.
go back to reference Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, Van der Meer P (2008) Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52:818–827PubMedCrossRef Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, Van der Meer P (2008) Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52:818–827PubMedCrossRef
8.
go back to reference van der Meer P, van Veldhuisen DJ (2009) Anaemia and renal dysfunction in chronic heart failure. Heart 95:1808–1812PubMedCrossRef van der Meer P, van Veldhuisen DJ (2009) Anaemia and renal dysfunction in chronic heart failure. Heart 95:1808–1812PubMedCrossRef
9.
go back to reference Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D (2006) Anemia, chronic renal disease and congestive heart failure–the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 38:295–310PubMedCrossRef Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D (2006) Anemia, chronic renal disease and congestive heart failure–the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 38:295–310PubMedCrossRef
10.
go back to reference Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G, Hillege HL, van Gilst WH, van Veldhuisen DJ (2007) Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 28:166–171PubMedCrossRef Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G, Hillege HL, van Gilst WH, van Veldhuisen DJ (2007) Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 28:166–171PubMedCrossRef
11.
go back to reference Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448PubMedCrossRef Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448PubMedCrossRef
12.
go back to reference Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL (2004) Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 147:924–930PubMedCrossRef Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL (2004) Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 147:924–930PubMedCrossRef
13.
go back to reference Klip IT, Comin Colet J, Voors AA, van der Meer P (Submitted) Iron deficiency in chronic heart failure: an international pooled analysis Klip IT, Comin Colet J, Voors AA, van der Meer P (Submitted) Iron deficiency in chronic heart failure: an international pooled analysis
14.
go back to reference van der Meer P, Lok DJ, Januzzi JL, de la Porte PW, Lipsic E, van Wijngaarden J, Voors AA, van Gilst WH, van Veldhuisen DJ (2008) Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Eur Heart J 29:1510–1515PubMedCrossRef van der Meer P, Lok DJ, Januzzi JL, de la Porte PW, Lipsic E, van Wijngaarden J, Voors AA, van Gilst WH, van Veldhuisen DJ (2008) Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Eur Heart J 29:1510–1515PubMedCrossRef
15.
go back to reference Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH (2010) Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 12(7):676–684PubMedCrossRef Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH (2010) Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 12(7):676–684PubMedCrossRef
16.
go back to reference van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH (2005) Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112:1743–1747PubMedCrossRef van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH (2005) Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112:1743–1747PubMedCrossRef
17.
go back to reference Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, Herzog CA (2005) Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 45:391–399PubMedCrossRef Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, Herzog CA (2005) Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 45:391–399PubMedCrossRef
18.
go back to reference Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA (2006) The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 27:1440–1446PubMedCrossRef Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA (2006) The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 27:1440–1446PubMedCrossRef
19.
go back to reference Herzog CA, Muster HA, Li S, Collins AJ (2004) Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the medicare population. J Card Fail 10:467–472PubMedCrossRef Herzog CA, Muster HA, Li S, Collins AJ (2004) Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the medicare population. J Card Fail 10:467–472PubMedCrossRef
20.
go back to reference Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM (2003) Hemodilution is common in patients with advanced heart failure. Circulation 107:226–229PubMedCrossRef Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM (2003) Hemodilution is common in patients with advanced heart failure. Circulation 107:226–229PubMedCrossRef
21.
go back to reference Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9:440–449PubMedCrossRef Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9:440–449PubMedCrossRef
22.
go back to reference Pressler SJ (2008) Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J Cardiovasc Nurs 23:239–249PubMedCrossRef Pressler SJ (2008) Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J Cardiovasc Nurs 23:239–249PubMedCrossRef
23.
go back to reference van den Hurk K, Reijmer YD, van den Berg E, Alssema M, Nijpels G, Kostense PJ, Stehouwer CD, Paulus WJ, Kamp O, Dekker JM, Biessels GJ (2011) Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail 13:1362–1369PubMedCrossRef van den Hurk K, Reijmer YD, van den Berg E, Alssema M, Nijpels G, Kostense PJ, Stehouwer CD, Paulus WJ, Kamp O, Dekker JM, Biessels GJ (2011) Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail 13:1362–1369PubMedCrossRef
24.
25.
go back to reference Kindermann I, Fischer D, Karbach J, Link A, Walenta K, Barth C, Ukena C, Mahfoud F, Kollner V, Kindermann M, Bohm M (2012) Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail 14:404–413PubMedCrossRef Kindermann I, Fischer D, Karbach J, Link A, Walenta K, Barth C, Ukena C, Mahfoud F, Kollner V, Kindermann M, Bohm M (2012) Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail 14:404–413PubMedCrossRef
26.
go back to reference Luijckx GJ, van den Berg MP (2011) Heart failure and the brain, a wake-up call. Eur J Heart Fail 13:597–598PubMedCrossRef Luijckx GJ, van den Berg MP (2011) Heart failure and the brain, a wake-up call. Eur J Heart Fail 13:597–598PubMedCrossRef
27.
go back to reference Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV (2003) Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290:2581–2587PubMedCrossRef Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV (2003) Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290:2581–2587PubMedCrossRef
28.
go back to reference Zuccala G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, Lo Monaco MR, Cocchi A, Carbonin P, Bernabei R (2003) The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 115:97–103PubMedCrossRef Zuccala G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, Lo Monaco MR, Cocchi A, Carbonin P, Bernabei R (2003) The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 115:97–103PubMedCrossRef
29.
go back to reference Dickson VV, Tkacs N, Riegel B (2007) Cognitive influences on self-care decision making in persons with heart failure. Am Heart J 154:424–431PubMedCrossRef Dickson VV, Tkacs N, Riegel B (2007) Cognitive influences on self-care decision making in persons with heart failure. Am Heart J 154:424–431PubMedCrossRef
30.
go back to reference Gosker HR, Wouters EF, van der Vusse GJ, Schols AM (2000) Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71:1033–1047PubMed Gosker HR, Wouters EF, van der Vusse GJ, Schols AM (2000) Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71:1033–1047PubMed
31.
go back to reference Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139PubMedCrossRef Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139PubMedCrossRef
32.
go back to reference Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, Macintyre K, McMurray JJ (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 12:17–24PubMedCrossRef Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, Macintyre K, McMurray JJ (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 12:17–24PubMedCrossRef
33.
go back to reference Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, ECHOS Lung Function Study Group (2010) The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 12:685–691PubMedCrossRef Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, ECHOS Lung Function Study Group (2010) The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 12:685–691PubMedCrossRef
34.
35.
go back to reference Wouters EF (2005) Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:26–33PubMedCrossRef Wouters EF (2005) Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:26–33PubMedCrossRef
36.
go back to reference Dimopoulou I, Daganou M, Tsintzas OK, Tzelepis GE (1998) Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 92:1321–1325PubMedCrossRef Dimopoulou I, Daganou M, Tsintzas OK, Tzelepis GE (1998) Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 92:1321–1325PubMedCrossRef
37.
go back to reference Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Ionescu AA, Cockcroft JR, Shale DJ (2010) Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 104:1171–1178PubMedCrossRef Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Ionescu AA, Cockcroft JR, Shale DJ (2010) Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 104:1171–1178PubMedCrossRef
38.
39.
go back to reference Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, Varricchio M, Rengo F (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 23:213–218PubMed Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, Varricchio M, Rengo F (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 23:213–218PubMed
40.
go back to reference Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34PubMedCrossRef Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34PubMedCrossRef
41.
go back to reference Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S (2000) Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21:1368–1375PubMedCrossRef Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S (2000) Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21:1368–1375PubMedCrossRef
42.
go back to reference From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL (2006) Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119:591–599PubMedCrossRef From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL (2006) Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119:591–599PubMedCrossRef
44.
go back to reference Shah AM, Uno H, Kober L, Velazquez EJ, Maggioni AP, MacDonald MR, Petrie MC, McMurray JJ, Califf RM, Pfeffer MA, Solomon SD (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail 12:1229–1237PubMedCrossRef Shah AM, Uno H, Kober L, Velazquez EJ, Maggioni AP, MacDonald MR, Petrie MC, McMurray JJ, Califf RM, Pfeffer MA, Solomon SD (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail 12:1229–1237PubMedCrossRef
45.
go back to reference Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ (2001) Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 38:421–428PubMedCrossRef Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ (2001) Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 38:421–428PubMedCrossRef
46.
go back to reference Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120–126PubMedCrossRef Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120–126PubMedCrossRef
47.
go back to reference Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40CrossRef Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40CrossRef
48.
go back to reference Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J (2008) Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 94:296–304PubMedCrossRef Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J (2008) Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 94:296–304PubMedCrossRef
49.
go back to reference Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ, CIBIS-2 Investigators and Committees (2010) Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12:974–982PubMedCrossRef Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ, CIBIS-2 Investigators and Committees (2010) Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12:974–982PubMedCrossRef
50.
go back to reference Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T, Heinisch C, Noveanu M, Frischknecht B, Baumann U, Jaeger KA, Mueller C (2011) Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail 13:432–439PubMedCrossRef Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T, Heinisch C, Noveanu M, Frischknecht B, Baumann U, Jaeger KA, Mueller C (2011) Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail 13:432–439PubMedCrossRef
51.
go back to reference Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA (2012) The role of the kidney in heart failure. Eur Heart J 33:2135–2142PubMedCrossRef Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA (2012) The role of the kidney in heart failure. Eur Heart J 33:2135–2142PubMedCrossRef
52.
go back to reference Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878PubMedCrossRef Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878PubMedCrossRef
53.
go back to reference Jois P, Mebazaa A (2012) Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. Semin Nephrol 32:26–30PubMedCrossRef Jois P, Mebazaa A (2012) Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. Semin Nephrol 32:26–30PubMedCrossRef
54.
go back to reference Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House A, Katz NM, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P, Acute Dialysis Quality Initiative (ADQI) consensus group (2010) Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 165:54–67PubMedCrossRef Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House A, Katz NM, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P, Acute Dialysis Quality Initiative (ADQI) consensus group (2010) Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 165:54–67PubMedCrossRef
55.
go back to reference Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678PubMedCrossRef Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678PubMedCrossRef
56.
go back to reference Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13:599–608PubMedCrossRef Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13:599–608PubMedCrossRef
57.
go back to reference Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMedCrossRef Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMedCrossRef
59.
go back to reference Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11:170–177PubMedCrossRef Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11:170–177PubMedCrossRef
60.
go back to reference Lau GT, Tan HC, Kritharides L (2002) Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 90:1405–1409PubMedCrossRef Lau GT, Tan HC, Kritharides L (2002) Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 90:1405–1409PubMedCrossRef
61.
go back to reference Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate II, Clinical Investigators (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120:2352–2357PubMedCrossRef Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate II, Clinical Investigators (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120:2352–2357PubMedCrossRef
62.
go back to reference Kubo SH, Walter BA, John DH, Clark M, Cody RJ (1987) Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med 147:1227–1230PubMedCrossRef Kubo SH, Walter BA, John DH, Clark M, Cody RJ (1987) Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med 147:1227–1230PubMedCrossRef
63.
go back to reference Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140:111–120PubMedCrossRef Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140:111–120PubMedCrossRef
64.
go back to reference Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, Maggioni AP, Swedberg K, Konstam MA, Zannad F, Gheorghiade M, EVEREST trial investigators (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302–311PubMedCrossRef Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, Maggioni AP, Swedberg K, Konstam MA, Zannad F, Gheorghiade M, EVEREST trial investigators (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302–311PubMedCrossRef
65.
go back to reference Bordier P (2009) Sleep apnoea in patients with heart failure. Part I: diagnosis, definitions, prevalence, pathophysiology and haemodynamic consequences. Arch Cardiovasc Dis 102:651–661PubMedCrossRef Bordier P (2009) Sleep apnoea in patients with heart failure. Part I: diagnosis, definitions, prevalence, pathophysiology and haemodynamic consequences. Arch Cardiovasc Dis 102:651–661PubMedCrossRef
66.
go back to reference Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235PubMedCrossRef Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235PubMedCrossRef
67.
go back to reference Muller M, de Jong M, Jaarsma T, Koops A, Voors AA, Nieuwenhuis JA, Wijkstra PJ (2010) Central sleep apnoea syndrome in chronic heart failure: an underestimated and treatable comorbidity. Neth Heart J 18:260–263PubMedCentralPubMedCrossRef Muller M, de Jong M, Jaarsma T, Koops A, Voors AA, Nieuwenhuis JA, Wijkstra PJ (2010) Central sleep apnoea syndrome in chronic heart failure: an underestimated and treatable comorbidity. Neth Heart J 18:260–263PubMedCentralPubMedCrossRef
68.
go back to reference Meguro K, Adachi H, Oshima S, Taniguchi K, Nagai R (2005) Exercise tolerance, exercise hyperpnea and central chemosensitivity to carbon dioxide in sleep apnea syndrome in heart failure patients. Circ J 69:695–699PubMedCrossRef Meguro K, Adachi H, Oshima S, Taniguchi K, Nagai R (2005) Exercise tolerance, exercise hyperpnea and central chemosensitivity to carbon dioxide in sleep apnea syndrome in heart failure patients. Circ J 69:695–699PubMedCrossRef
69.
go back to reference Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93PubMedCrossRef Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93PubMedCrossRef
70.
go back to reference Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L, Drouot X, Lamine A, Paulino A, Rappeneau S, Stoica MH, Dubois-Rande JL, Adnot S, Hittinger L, d’Ortho MP (2012) Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 14(9):1009–1019PubMedCrossRef Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L, Drouot X, Lamine A, Paulino A, Rappeneau S, Stoica MH, Dubois-Rande JL, Adnot S, Hittinger L, d’Ortho MP (2012) Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 14(9):1009–1019PubMedCrossRef
71.
go back to reference Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, Arzt M (2011) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13:68–75PubMedCrossRef Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, Arzt M (2011) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13:68–75PubMedCrossRef
72.
go back to reference Kannel WB, Wolf PA, Verter J (1983) Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 250:2942–2946 Kannel WB, Wolf PA, Verter J (1983) Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 250:2942–2946
73.
go back to reference Haeusler KG, Laufs U, Endres M (2011) Chronic heart failure and ischemic stroke. Stroke 42:2977–2982PubMedCrossRef Haeusler KG, Laufs U, Endres M (2011) Chronic heart failure and ischemic stroke. Stroke 42:2977–2982PubMedCrossRef
74.
go back to reference Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 9:1003–1009PubMedCrossRef Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 9:1003–1009PubMedCrossRef
75.
go back to reference Pullicino PM, Halperin JL, Thompson JL (2000) Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology 54:288–294PubMedCrossRef Pullicino PM, Halperin JL, Thompson JL (2000) Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology 54:288–294PubMedCrossRef
76.
go back to reference Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988PubMedCrossRef Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988PubMedCrossRef
77.
go back to reference Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I (2009) Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J 50:591–600PubMedCrossRef Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I (2009) Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J 50:591–600PubMedCrossRef
78.
go back to reference Lip GY, Gibbs CR (1999) Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol 33:1424–1426PubMedCrossRef Lip GY, Gibbs CR (1999) Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol 33:1424–1426PubMedCrossRef
79.
go back to reference Divani AA, Vazquez G, Asadollahi M, Qureshi AI, Pullicino P (2009) Nationwide frequency and association of heart failure on stroke outcomes in the United States. J Card Fail 15:11–16PubMedCrossRef Divani AA, Vazquez G, Asadollahi M, Qureshi AI, Pullicino P (2009) Nationwide frequency and association of heart failure on stroke outcomes in the United States. J Card Fail 15:11–16PubMedCrossRef
80.
go back to reference Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R (1997) Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 63:509–512PubMedCrossRef Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R (1997) Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 63:509–512PubMedCrossRef
81.
go back to reference Bennett SJ, Sauve MJ (2003) Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 18:219–242PubMedCrossRef Bennett SJ, Sauve MJ (2003) Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 18:219–242PubMedCrossRef
82.
go back to reference Grimm M, Yeganehfar W, Laufer G, Madl C, Kramer L, Eisenhuber E, Simon P, Kupilik N, Schreiner W, Pacher R, Bunzel B, Wolner E, Grimm G (1996) Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation 94:1339–1345PubMedCrossRef Grimm M, Yeganehfar W, Laufer G, Madl C, Kramer L, Eisenhuber E, Simon P, Kupilik N, Schreiner W, Pacher R, Bunzel B, Wolner E, Grimm G (1996) Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation 94:1339–1345PubMedCrossRef
83.
go back to reference Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ (1997) Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol 19:692–697PubMedCrossRef Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ (1997) Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol 19:692–697PubMedCrossRef
84.
go back to reference Millar K, Asbury AJ, Murray GD (2001) Pre-existing cognitive impairment as a factor influencing outcome after cardiac surgery. Br J Anaesth 86:63–67PubMedCrossRef Millar K, Asbury AJ, Murray GD (2001) Pre-existing cognitive impairment as a factor influencing outcome after cardiac surgery. Br J Anaesth 86:63–67PubMedCrossRef
85.
go back to reference Schwarz ER, Rastogi S, Kapur V, Sulemanjee N, Rodriguez JJ (2006) Erectile dysfunction in heart failure patients. J Am Coll Cardiol 48:1111–1119PubMedCrossRef Schwarz ER, Rastogi S, Kapur V, Sulemanjee N, Rodriguez JJ (2006) Erectile dysfunction in heart failure patients. J Am Coll Cardiol 48:1111–1119PubMedCrossRef
86.
go back to reference Baraghoush A, Phan A, Willix RD Jr, Schwarz ER (2010) Erectile dysfunction as a complication of heart failure. Curr Heart Fail Rep 7:194–201PubMedCrossRef Baraghoush A, Phan A, Willix RD Jr, Schwarz ER (2010) Erectile dysfunction as a complication of heart failure. Curr Heart Fail Rep 7:194–201PubMedCrossRef
87.
go back to reference Saxena PR, Schoemaker RG (1993) Organ blood flow protection in hypertension and congestive heart failure. Am J Med 94:4S–12SPubMedCrossRef Saxena PR, Schoemaker RG (1993) Organ blood flow protection in hypertension and congestive heart failure. Am J Med 94:4S–12SPubMedCrossRef
88.
go back to reference Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41:1797–1804PubMedCrossRef Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41:1797–1804PubMedCrossRef
Metadata
Title
Co-morbidities in heart failure
Authors
Vincent M. van Deursen
Kevin Damman
Peter van der Meer
Peter J. Wijkstra
Gert-Jan Luijckx
Andre van Beek
Dirk J. van Veldhuisen
Adriaan A. Voors
Publication date
01-03-2014
Publisher
Springer US
Published in
Heart Failure Reviews / Issue 2/2014
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-012-9370-7

Other articles of this Issue 2/2014

Heart Failure Reviews 2/2014 Go to the issue